DS

Daniel J. Sexton

DY Dyax: 20 patents #4 of 129Top 4%
TL Takeda Pharmaceutical Company Limited: 19 patents #33 of 1,531Top 3%
BS Bracco Suisse Sa: 2 patents #36 of 63Top 60%
📍 Melrose, MA: #13 of 446 inventorsTop 3%
🗺 Massachusetts: #1,962 of 88,656 inventorsTop 3%
Overall (All Time): #80,362 of 4,157,543Top 2%
39
Patents All Time

Issued Patents All Time

Showing 26–39 of 39 patents

Patent #TitleCo-InventorsDate
10428158 Compositions and methods for treatment of diabetic macular edema Gregory P. Conley, Andrew Nixon 2019-10-01
10370453 Plasma kallikrein binding proteins Malini Viswanathan 2019-08-06
10336832 Methods of inhibiting plasma kallikrein in edema patient Malini Viswanathan 2019-07-02
10101344 Diagnosis and treatment of autoimmune diseases Burt Adelman, Andrew Nixon 2018-10-16
9862768 Methods of producing antibodies to neonatal Fc receptor (FcRn) Christopher TenHoor, Malini Viswanathan 2018-01-09
9629934 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Aaron Sato, Daniel T. Dransfield, Robert Charles Ladner 2017-04-25
9446155 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Aaron Sato, Daniel T. Dransfield, Robert Charles Ladner, Christophe Arbogast, Philippe Bussat +14 more 2016-09-20
9359438 Human neonatal Fc receptor antibodies and methods of use thereof Christopher TenHoor, Malini Viswanathan 2016-06-07
9266964 Method of treating hereditary angioedema using plasma kallikrein binding antibodies Malini Viswanathan 2016-02-23
8822653 Plasma kallikrein binding proteins Malini Viswanathan 2014-09-02
8816055 Plasma kallikrein binding proteins Malini Viswanathan 2014-08-26
8642010 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Aaron Sato, Daniel T. Dransfield, Robert Charles Ladner, Christophe Arbogast, Philippe Bussat +14 more 2014-02-04
7993646 HK1-binding proteins Andrew Nixon, Anthony Williams, Robert Charles Ladner, Qi-Long Wu 2011-08-09
7329737 Antibodies that bind hK-1 Andrew Nixon, Anthony Williams, Robert Charles Ladner, Qi-Long Wu 2008-02-12